Literature DB >> 26620949

Mild primary hyperparathyroidism as defined in the Italian Society of Endocrinology's Consensus Statement: prevalence and clinical features.

E Castellano1, F Tassone2, R Attanasio3, L Gianotti2, M Pellegrino2, G Borretta2.   

Abstract

BACKGROUND: Mild primary hyperparathyroidism (PHPT) was recently clearly defined for the first time. Our study was thus aimed to pinpoint proportion and clinical characteristics of this kind of patients. DESIGN AND PATIENTS: We retrospectively evaluated our series of 360 consecutive patients with PHPT, selecting those with all features allowing a correct classification (serum total and ionized calcium, phosphate, creatinine, PTH, 25OHD, urinary calcium, renal and neck ultrasound, MIBI scintiscan, and DEXA at lumbar spine, femoral neck, and distal third of radius). Patients were defined asymptomatic (aPHPT) when bone or kidney was not involved and no hypercalcemic symptom occurred; mild PHPT was defined as aPHPT not meeting updated surgical criteria.
RESULTS: Seventy-five patients among 172 classified as aPHPT had all available data required for surgical evaluation and could be evaluated. Sixty/75 met surgical criteria and the remaining 15 were classified as mild. Mild PHPT patients had lower total and ionized calcium, urinary calcium, and PTH levels than aPHPT meeting surgical criteria, while vitamin D levels and BMD were similar.
CONCLUSIONS: Mild PHPT strictly defined according to the last consensus represents a small subgroup with a less active form of the disease.

Entities:  

Keywords:  Clinical features; Definition; Mild primary hyperparathyroidism; Prevalence

Mesh:

Year:  2015        PMID: 26620949     DOI: 10.1007/s40618-015-0412-6

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.

Authors:  C Marcocci; M L Brandi; A Scillitani; S Corbetta; A Faggiano; L Gianotti; S Migliaccio; S Minisola
Journal:  J Endocrinol Invest       Date:  2015-03-28       Impact factor: 4.256

Review 2.  Diagnosis and management of asymptomatic primary hyperparathyroidism. National Institutes of Health Consensus Development Conference. October 29-31, 1990.

Authors: 
Journal:  Consens Statement       Date:  1990 Oct 29-31

3.  Aortic valve calcification in mild primary hyperparathyroidism.

Authors:  Shinichi Iwata; Marcella Donovan Walker; Marco R Di Tullio; Eiichi Hyodo; Zhezhen Jin; Rui Liu; Ralph L Sacco; Shunichi Homma; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2011-10-26       Impact factor: 5.958

Review 4.  Hypercalcemic crisis.

Authors:  R Ziegler
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

Review 5.  Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism.

Authors:  Jens Bollerslev; Claudio Marcocci; Manuel Sosa; Jörgen Nordenström; Roger Bouillon; Leif Mosekilde
Journal:  Eur J Endocrinol       Date:  2011-09-29       Impact factor: 6.664

6.  Surgery for 'asymptomatic' mild primary hyperparathyroidism improves some clinical symptoms postoperatively.

Authors:  Claire Blanchard; Muriel Mathonnet; Frédéric Sebag; Cécile Caillard; Antoine Hamy; Christelle Volteau; Marie-Françoise Heymann; Vincent Wyart; Delphine Drui; Malanie Roy; Bertrand Cariou; Françoise Archambeaud; Patrice Rodien; Jean-François Henry; Rasa Zarnegar; Jean-Benoît Hardouin; Eric Mirallié
Journal:  Eur J Endocrinol       Date:  2013-10-03       Impact factor: 6.664

Review 7.  Asymptomatic and mild primary hyperparathyroidism.

Authors:  David P Macfarlane; Ning Yu; Graham P Leese
Journal:  Ann Endocrinol (Paris)       Date:  2015-04-14       Impact factor: 2.478

8.  Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.

Authors:  Jens Bollerslev; Svante Jansson; Charlotte L Mollerup; Jörgen Nordenström; Eva Lundgren; Ove Tørring; Jan-Erik Varhaug; Marek Baranowski; Sylvi Aanderud; Celina Franco; Bo Freyschuss; Gunhild A Isaksen; Thor Ueland; Thord Rosen
Journal:  J Clin Endocrinol Metab       Date:  2007-02-06       Impact factor: 5.958

Review 9.  Asymptomatic primary hyperparathyroidism.

Authors:  Shonni J Silverberg; Marcella D Walker; John P Bilezikian
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

10.  Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism.

Authors:  Edda Vignali; Giuseppe Viccica; Daniele Diacinti; Filomena Cetani; Luisella Cianferotti; Elena Ambrogini; Chiara Banti; Romano Del Fiacco; John P Bilezikian; Aldo Pinchera; Claudio Marcocci
Journal:  J Clin Endocrinol Metab       Date:  2009-04-28       Impact factor: 5.958

View more
  5 in total

1.  Less is more: time to expand the indications for minimally invasive video-assisted parathyroidectomy.

Authors:  S Bakkar; V Matteucci; C Corsini; S Pagliaro; P Miccoli
Journal:  J Endocrinol Invest       Date:  2017-04-03       Impact factor: 4.256

2.  PRIMARY HYPERPARATHYROIDISM DETECTED BY PARATHYROID INCIDENTALOMA: CLINICAL FEATURES, WORK-UP AND MANAGEMENT.

Authors:  V Pandzic Jaksic; A Majic; T Rezic; J Andric; O Jaksic; A Zrilic; S Marusic
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

3.  Clinical presentation and management of patients with primary hyperparathyroidism in Italy.

Authors:  F Saponaro; F Cetani; A Repaci; U Pagotto; C Cipriani; J Pepe; S Minisola; C Cipri; F Vescini; A Scillitani; A Salcuni; S Palmieri; C Eller-Vainicher; I Chiodini; B Madeo; E Kara; E Castellano; G Borretta; L Gianotti; F Romanelli; V Camozzi; A Faggiano; S Corbetta; L Cianferotti; M L Brandi; M L De Feo; A Palermo; G Vezzoli; F Maino; M Scalese; C Marcocci
Journal:  J Endocrinol Invest       Date:  2018-04-03       Impact factor: 4.256

4.  Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016.

Authors:  B Sun; B Guo; B Wu; J Kang; X Deng; Z Zhang; Y Fan
Journal:  Osteoporos Int       Date:  2017-12-03       Impact factor: 4.507

5.  "Silent" kidney stones in "asymptomatic" primary hyperparathyroidism-a comparison of multidetector computed tomography and ultrasound.

Authors:  Andreas Selberherr; Marcus Hörmann; Gerhard Prager; Philipp Riss; Christian Scheuba; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2016-10-12       Impact factor: 3.445

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.